{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:21:12Z","timestamp":1788315672106,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":365,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014228","name":"Duke Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014228","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30CA014236"],"award-info":[{"award-number":["P30CA014236"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["bbmt.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biology of Blood and Marrow Transplantation"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/j.bbmt.2020.05.007","type":"journal-article","created":{"date-parts":[[2020,5,22]],"date-time":"2020-05-22T21:49:15Z","timestamp":1590184155000},"page":"1597-1606","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function"],"prefix":"10.1016","volume":"26","author":[{"given":"Gena G.","family":"Foster","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael J.","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha M.","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blake","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"Raiff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Corbet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Loitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Ferreri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitchell","family":"Horwitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"6","key":"10.1016\/j.bbmt.2020.05.007_bib0001","doi-asserted-by":"crossref","first-page":"866","DOI":"10.2215\/CJN.10630917","article-title":"Changes in glomerular filtration rate and impact on long-term survival among adults after hematopoietic cell transplantation: a prospective cohort study","volume":"13","author":"Hingorani","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"issue":"3","key":"10.1016\/j.bbmt.2020.05.007_bib0002","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.jcv.2011.06.008","article-title":"Deciphering the clinical impact of acute human herpesvirus 6 (HHV-6) infections","volume":"52","author":"Agut","year":"2011","journal-title":"J Clin Virol"},{"issue":"7","key":"10.1016\/j.bbmt.2020.05.007_bib0003","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1086\/428060","article-title":"Clinical outcomes of human herpesvirus 6 reactivation after hematopoietic stem cell transplantation","volume":"40","author":"Zerr","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"3","key":"10.1016\/j.bbmt.2020.05.007_bib0004","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1038\/sj.bmt.1705907","article-title":"Plasma HHV-6 viral load-guided preemptive therapy against HHV-6 encephalopathy after allogeneic stem cell transplantation: a prospective evaluation","volume":"41","author":"Ogata","year":"2008","journal-title":"Bone Marrow Transplant"},{"issue":"10","key":"10.1016\/j.bbmt.2020.05.007_bib0005","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.bbmt.2009.06.019","article-title":"Guidelines for preventing infectious complications among hematopoietic cell transplantation recipients: a global perspective","volume":"15","author":"Tomblyn","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2020.05.007_bib0006","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1016\/j.jbi.2010.11.008","article-title":"The DEDUCE Guided Query tool: providing simplified access to clinical data for research and quality improvement","volume":"44","author":"Horvath","year":"2011","journal-title":"J Biomed Inform"},{"issue":"23","key":"10.1016\/j.bbmt.2020.05.007_bib0007","doi-asserted-by":"crossref","first-page":"3664","DOI":"10.1182\/blood-2014-01-552984","article-title":"Validation and refinement of the Disease Risk Index for allogeneic stem cell transplantation","volume":"123","author":"Armand","year":"2014","journal-title":"Blood"},{"issue":"8","key":"10.1016\/j.bbmt.2020.05.007_bib0008","doi-asserted-by":"crossref","first-page":"2912","DOI":"10.1182\/blood-2005-05-2004","article-title":"Hematopoietic cell transplantation (HCT)-specific comorbidity index: a new tool for risk assessment before allogeneic HCT","volume":"106","author":"Sorror","year":"2005","journal-title":"Blood"},{"issue":"12","key":"10.1016\/j.bbmt.2020.05.007_bib0009","first-page":"5S","article-title":"Medication use evaluation: pharmacist rubric for performance improvement","volume":"34","author":"Fanikos","year":"2014","journal-title":"Pharmacotherapy"},{"issue":"9","key":"10.1016\/j.bbmt.2020.05.007_bib0010","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"issue":"4","key":"10.1016\/j.bbmt.2020.05.007_bib0011","doi-asserted-by":"crossref","first-page":"R204","DOI":"10.1186\/cc2872","article-title":"Acute renal failure\u2014definition, outcome measures, animal models, fluid therapy and information technology needs: the Second International Consensus Conference of the Acute Dialysis Quality Initiative (ADQI) Group","volume":"8","author":"Bellomo","year":"2004","journal-title":"Crit Care"},{"issue":"12","key":"10.1016\/j.bbmt.2020.05.007_bib0012","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/j.bbmt.2005.09.004","article-title":"National Institutes of Health consensus development project on criteria for clinical trials in chronic graft-versus-host disease, I: diagnosis and staging working group report","volume":"11","author":"Filipovich","year":"2005","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/j.bbmt.2020.05.007_bib0013","unstructured":"Foscavir (foscarnet sodium) [package insert].Wilmington, DE: AstraZeneca; 2006"},{"issue":"23","key":"10.1016\/j.bbmt.2020.05.007_bib0014","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1056\/NEJMra1404711","article-title":"Renal complications of hematopoietic-cell transplantation","volume":"374","author":"Hingorani","year":"2016","journal-title":"N Engl J Med"},{"issue":"6","key":"10.1016\/j.bbmt.2020.05.007_bib0015","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.bbmt.2008.03.008","article-title":"Similar risks for chronic kidney disease in long-term survivors of myeloablative and reduced-intensity allogeneic hematopoietic cell transplantation","volume":"14","author":"Al-Hazzouri","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"issue":"5","key":"10.1016\/j.bbmt.2020.05.007_bib0016","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1038\/bmt.2016.343","article-title":"Long term renal survival in patients undergoing T-cell depleted versus conventional hematopoietic stem cell transplants","volume":"52","author":"Glezerman","year":"2017","journal-title":"Bone Marrow Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2020.05.007_bib0017","doi-asserted-by":"crossref","first-page":"1710","DOI":"10.1681\/ASN.2005111200","article-title":"Racial differences in the prevalence of chronic kidney disease among participants in the Reasons for Geographic and Racial Differences in Stroke (REGARDS) cohort study","volume":"17","author":"McClellan","year":"2006","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"10.1016\/j.bbmt.2020.05.007_bib0018","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1159\/000167987","article-title":"Foscarnet nephrotoxicity: mechanism, incidence and prevention","volume":"9","author":"Deray","year":"1989","journal-title":"Am J Nephrol"},{"issue":"4","key":"10.1016\/j.bbmt.2020.05.007_bib0019","doi-asserted-by":"crossref","first-page":"e12920","DOI":"10.1111\/ctr.12920","article-title":"Long-term renal outcome after allogeneic hemopoietic stem cell transplant: a comprehensive analysis of risk factors in an Asian patient population","volume":"31","author":"Zhou","year":"2017","journal-title":"Clin Transplant"},{"issue":"10","key":"10.1016\/j.bbmt.2020.05.007_bib0020","doi-asserted-by":"crossref","first-page":"e74","DOI":"10.1097\/TP.0000000000001418","article-title":"Outcomes in transplant recipients treated with foscarnet for ganciclovir-resistant or refractory cytomegalovirus infection","volume":"100","author":"Avery","year":"2016","journal-title":"Transplantation"},{"issue":"10","key":"10.1016\/j.bbmt.2020.05.007_bib0021","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1016\/j.bbmt.2011.04.004","article-title":"Human herpesvirus 6 infection after hematopoietic cell transplantation: is routine surveillance necessary?","volume":"17","author":"Betts","year":"2011","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"10.1016\/j.bbmt.2020.05.007_bib0022","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s40121-017-0180-z","article-title":"Who is the patient at risk of CMV recurrence: a review of the current scientific evidence with a focus on hematopoietic cell transplantation","volume":"7","author":"Styczynski","year":"2018","journal-title":"Infect Dis Ther"},{"issue":"24","key":"10.1016\/j.bbmt.2020.05.007_bib0023","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1001\/jama.2014.6634","article-title":"Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality","volume":"311","author":"Coresh","year":"2014","journal-title":"JAMA"},{"issue":"10","key":"10.1016\/j.bbmt.2020.05.007_bib0024","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.bbmt.2009.05.016","article-title":"Chronic kidney dysfunction in patients alive without relapse 2 years after allogeneic hematopoietic stem cell transplantation","volume":"15","author":"Abboud","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"10.1016\/j.bbmt.2020.05.007_bib0025","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1093\/ndt\/gfp529","article-title":"Long-term renal function after allogenic haematopoietic stem cell transplantation in adult patients: a single-centre study","volume":"25","author":"Touzot","year":"2010","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"10.1016\/j.bbmt.2020.05.007_bib0026","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/sj.bmt.1705573","article-title":"Chronic kidney disease in long-term survivors of hematopoietic cell transplant","volume":"39","author":"Hingorani","year":"2007","journal-title":"Bone Marrow Transplant"},{"issue":"3","key":"10.1016\/j.bbmt.2020.05.007_bib0027","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ijrobp.2003.06.001","article-title":"Renal insufficiency in patients with hematologic malignancies undergoing total body irradiation and bone marrow transplantation: a prospective assessment","volume":"58","author":"Miralbell","year":"2004","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"2","key":"10.1016\/j.bbmt.2020.05.007_bib0028","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2215\/CJN.04800908","article-title":"Calcineurin inhibitor nephrotoxicity","volume":"4","author":"Naesens","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"10.1016\/j.bbmt.2020.05.007_bib0029","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1111\/j.1600-6143.2008.02408.x","article-title":"Chronic kidney disease after hematopoietic cell transplantation: a systematic review","volume":"8","author":"Ellis","year":"2008","journal-title":"Am J Transplant"},{"issue":"6","key":"10.1016\/j.bbmt.2020.05.007_bib0030","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1016\/j.bbmt.2018.02.008","article-title":"Effects of prophylactic foscarnet on human herpesvirus-6 reactivation and encephalitis in cord blood transplant recipients: a prospective multicenter trial with an historical control group","volume":"24","author":"Ogata","year":"2018","journal-title":"Biol Blood Marrow Transplant"}],"container-title":["Biology of Blood and Marrow Transplantation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1083879120302950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T15:12:19Z","timestamp":1761059539000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1083879120302950"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S1083879120302950"],"URL":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.05.007","relation":{},"ISSN":["1083-8791"],"issn-type":[{"value":"1083-8791","type":"print"}],"subject":[],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment with Foscarnet after Allogeneic Hematopoietic Cell Transplant (Allo-HCT) Is Associated with Long-Term Loss of Renal Function","name":"articletitle","label":"Article Title"},{"value":"Biology of Blood and Marrow Transplantation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.bbmt.2020.05.007","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 American Society for Transplantation and Cellular Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}